Long pentraxin 3: Experimental and clinical relevance in cardiovascular diseases
Pentraxin 3 (PTX3) is an essential component of the humoral arm of innate immunity and belongs, together with the C-reactive protein (CRP) and other acute phase proteins, to the pentraxins' superfamily: soluble, multifunctional, pattern recognition proteins. Pentraxins share a common C-terminal...
| Main Authors: | , , , |
|---|---|
| Format: | Journal Article |
| Published: |
Hindawi Publishing Corporation
2013
|
| Online Access: | http://hdl.handle.net/20.500.11937/55760 |
Similar Items
Long pentraxin PTX3 as a prognostic marker of cardiovascular mortality in patients with chronic kidney disease
by: Baragetti, A., et al.
Published: (2017)
by: Baragetti, A., et al.
Published: (2017)
Pentraxins and atherosclerosis
by: Barbati, E., et al.
Published: (2014)
by: Barbati, E., et al.
Published: (2014)
Translating the biology of adipokines in atherosclerosis and cardiovascular diseases: Gaps and open questions
by: Ruscica, M., et al.
Published: (2017)
by: Ruscica, M., et al.
Published: (2017)
Vascular pentraxin 3 controls arterial thrombosis by targeting collagen and fibrinogen induced platelets aggregation
by: Bonacina, F., et al.
Published: (2016)
by: Bonacina, F., et al.
Published: (2016)
Pentraxin 3 (PTX3) plasma levels and carotid intima media thickness progression in the general population
by: Baragetti, A., et al.
Published: (2014)
by: Baragetti, A., et al.
Published: (2014)
Niemann-pick C1-like 1 (NPC1L1) inhibition and cardiovascular diseases
by: Pirillo, A., et al.
Published: (2016)
by: Pirillo, A., et al.
Published: (2016)
Trained immunity and cardiovascular disease: Is it time for translation to humans?
by: Norata, Giuseppe
Published: (2018)
by: Norata, Giuseppe
Published: (2018)
Long pentraxin 3/tumor necrosis factor-stimulated gene-6 interaction a biological rheostat for fibroblast growth factor 2-mediated angiogenesis
by: Leali, D., et al.
Published: (2012)
by: Leali, D., et al.
Published: (2012)
The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis
by: Pirillo, A., et al.
Published: (2018)
by: Pirillo, A., et al.
Published: (2018)
HDL in innate and adaptive immunity
by: Catapano, A., et al.
Published: (2014)
by: Catapano, A., et al.
Published: (2014)
IDOL N342S variant, atherosclerosis progression and cardiovascular disorders in the italian general population
by: Dhyani, A., et al.
Published: (2015)
by: Dhyani, A., et al.
Published: (2015)
Genetically determined telomeres shortening is associated with carotid atherosclerosis progression and increased incidence of cardiovascular events
by: Baragetti, A., et al.
Published: (2016)
by: Baragetti, A., et al.
Published: (2016)
Epicardial Adipose Tissue (EAT) thickness is associated with cardiovascular and liver damage in nonalcoholic fatty liver disease
by: Fracanzani, A., et al.
Published: (2016)
by: Fracanzani, A., et al.
Published: (2016)
HDL in infectious diseases and sepsis
by: Pirillo, A., et al.
Published: (2015)
by: Pirillo, A., et al.
Published: (2015)
Therapy and clinical trials: Aggressive statin therapy versus combined and emerging approaches
by: Catapano, A., et al.
Published: (2011)
by: Catapano, A., et al.
Published: (2011)
-374 T/A RAGE Polymorphism Is Associated with Chronic Kidney Disease Progression in Subjects Affected by Nephrocardiovascular Disease
by: Baragetti, I., et al.
Published: (2013)
by: Baragetti, I., et al.
Published: (2013)
Statins and skeletal muscles toxicity: From clinical trials to everyday practice
by: Norata, Giuseppe, et al.
Published: (2014)
by: Norata, Giuseppe, et al.
Published: (2014)
Vascular inflammation and low-density lipoproteins: Is cholesterol the link? A lesson from the clinical trials
by: Catapano, A., et al.
Published: (2017)
by: Catapano, A., et al.
Published: (2017)
Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up
by: Fracanzani, A., et al.
Published: (2016)
by: Fracanzani, A., et al.
Published: (2016)
Telomere shortening over 6 years is associated with increased subclinical carotid vascular damage and worse cardiovascular prognosis in the general population
by: Baragetti, A., et al.
Published: (2015)
by: Baragetti, A., et al.
Published: (2015)
The missing link between high-density lipoprotein cholesterol and inflammatory response in cardiovascular disease
by: Ammirati, E., et al.
Published: (2014)
by: Ammirati, E., et al.
Published: (2014)
High density lipoprotein cholesterol levels are an independent predictor of the progression of chronic kidney disease
by: Baragetti, A., et al.
Published: (2013)
by: Baragetti, A., et al.
Published: (2013)
The predictive and diagnostic accuracy of vascular endothelial growth factor and pentraxin-3 in severe dengue
by: Kim, Gary Kuan Low, et al.
Published: (2018)
by: Kim, Gary Kuan Low, et al.
Published: (2018)
The Predictive And Diagnostic Accuracy Of Pentraxin-3 And Vascular Endothelial Growth Factor In Severe Dengue
by: Low, Gary Kim Kuan
Published: (2019)
by: Low, Gary Kim Kuan
Published: (2019)
PCSK9 deficiency results in increased ectopic fat accumulation in experimental models and in humans
by: Baragetti, A., et al.
Published: (2017)
by: Baragetti, A., et al.
Published: (2017)
PI3K-C2B PLAYS A KEY ROLE IN THE ACTIVATION AND THE PROLIFERATION OF T LYMPHOCYTES: IMPACT ON VASCULAR DISEASES
by: Balzarotti, G., et al.
Published: (2015)
by: Balzarotti, G., et al.
Published: (2015)
Leonurine: A new comer in the natural compounds affecting atherosclerosis
by: Norata, Giuseppe, et al.
Published: (2012)
by: Norata, Giuseppe, et al.
Published: (2012)
Statins and periodontal inflammation: A pleiotropic effect of statins or a pleiotropic effect of LDL-cholesterol lowering?
by: Norata, Giuseppe, et al.
Published: (2014)
by: Norata, Giuseppe, et al.
Published: (2014)
HDL and adaptive immunity: A tale of lipid rafts
by: Norata, Giuseppe, et al.
Published: (2012)
by: Norata, Giuseppe, et al.
Published: (2012)
Cardiometabolic and immune factors associated with increased common carotid artery intima-media thickness and cardiovascular disease in patients with systemic lupus erythematosus
by: Ammirati, E., et al.
Published: (2014)
by: Ammirati, E., et al.
Published: (2014)
Computed tomography angiography: clinical applications in cardiovascular disease
by: Sun, Zhonghua
Published: (2012)
by: Sun, Zhonghua
Published: (2012)
PCSK9 inhibitors and dyslipidemia: The clinical evidence
by: Norata, Giuseppe
Published: (2014)
by: Norata, Giuseppe
Published: (2014)
High density lipoproteins and atherosclerosis: Emerging aspects
by: Sala, F., et al.
Published: (2012)
by: Sala, F., et al.
Published: (2012)
3D Computed Tomography Virtual Intravascular Endoscopy: Clinical Applications in Cardiovascular Disease.
by: Sun, Zhonghua
Published: (2013)
by: Sun, Zhonghua
Published: (2013)
The CD1d-natural killer T cell axis in atherosclerosis
by: Bondarenko, S., et al.
Published: (2014)
by: Bondarenko, S., et al.
Published: (2014)
Epidemiology of cardiovascular disease
by: Reid, Christopher, et al.
Published: (2016)
by: Reid, Christopher, et al.
Published: (2016)
Prevention of Cardiovascular Disease
by: Owen, A., et al.
Published: (2012)
by: Owen, A., et al.
Published: (2012)
High-density lipoprotein subfractions - What the clinicians need to know
by: Pirillo, A., et al.
Published: (2013)
by: Pirillo, A., et al.
Published: (2013)
LOX-1, OxLDL, and atherosclerosis
by: Pirillo, A., et al.
Published: (2013)
by: Pirillo, A., et al.
Published: (2013)
Treating high density lipoprotein cholesterol (HDL-C): Quantity versus quality
by: Pirillo, A., et al.
Published: (2013)
by: Pirillo, A., et al.
Published: (2013)